04:51 PM EST, 03/07/2024 (MT Newswires) -- Peter Greenleaf, Director, Chief Executive Officer, on March 06, 2024, sold 126,981 shares in Aurinia Pharmaceuticals ( AUPH ) for $711,094. Following the Form 4 filing with the SEC, Greenleaf has control over a total of 1,522,114 shares of the company, with 1,522,114 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1600620/000160062024000038/xslF345X03/wk-form4_1709847968.xml

Price: 5.51, Change: +0.06, Percent Change: +1.1